141 related articles for article (PubMed ID: 1594552)
1. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
Zentler-Munro PL; Assoufi BA; Balasubramanian K; Cornell S; Benoliel D; Northfield TC; Hodson ME
Pancreas; 1992; 7(3):311-9. PubMed ID: 1594552
[TBL] [Abstract][Full Text] [Related]
2. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
Stead RJ; Skypala I; Hodson ME; Batten JC
Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
[TBL] [Abstract][Full Text] [Related]
3. Increased intragastric acid-resistant lipase activity and lipolysis in pancreatic steatorrhoea due to cystic fibrosis.
Balasubramanian K; Zentler-Munro PL; Batten JC; Northfield TC
Pancreas; 1992; 7(3):305-10. PubMed ID: 1594551
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro studies of microsphere pancreatic supplements.
Littlewood JM; Kelleher J; Walters MP; Johnson AW
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
[TBL] [Abstract][Full Text] [Related]
6. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
Griffin SM; Alderson D; Farndon JR
Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
[TBL] [Abstract][Full Text] [Related]
7. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.
Lancellotti L; Cabrini G; Zanolla L; Mastella G
J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):73-8. PubMed ID: 8788291
[TBL] [Abstract][Full Text] [Related]
8. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.
Zentler-Munro PL; Fine DR; Batten JC; Northfield TC
Gut; 1985 Sep; 26(9):892-901. PubMed ID: 3849459
[TBL] [Abstract][Full Text] [Related]
9. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine.
Stead RJ; Skypala I; Hodson ME
Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four pancreatic extracts in cystic fibrosis.
Beverley DW; Kelleher J; MacDonald A; Littlewood JM; Robinson T; Walters MP
Arch Dis Child; 1987 Jun; 62(6):564-8. PubMed ID: 3304172
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
[TBL] [Abstract][Full Text] [Related]
13. Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis.
Beker LT; Fink RJ; Shamsa FH; Chaney HR; Kluft J; Evans E; Schidlow DV
J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):191-7. PubMed ID: 7815242
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
Gow R; Bradbear R; Francis P; Shepherd R
Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
[No Abstract] [Full Text] [Related]
15. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations.
Delchier JC; Vidon N; Saint-Marc Girardin MF; Soule JC; Moulin C; Huchet B; Zylberberg P
Aliment Pharmacol Ther; 1991 Aug; 5(4):365-78. PubMed ID: 1777547
[TBL] [Abstract][Full Text] [Related]
16. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
Opekun AR; Sutton FM; Graham DY
Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
[TBL] [Abstract][Full Text] [Related]
17. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Dutta SK; Hubbard VS; Appler M
Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
[TBL] [Abstract][Full Text] [Related]
19. Current concepts: pancreatic extracts.
Littman A; Hanscom DH
N Engl J Med; 1969 Jul; 281(4):201-4. PubMed ID: 4892805
[No Abstract] [Full Text] [Related]
20. Comparative trial of Nutrizym in chronic pancreatic insufficiency.
Knill-Jones RP; Pearce H; Batten J; Williams R
Br Med J; 1970 Oct; 4(5726):21-4. PubMed ID: 4919118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
